CompoAtlas

Neprinol AFD

Neprinol AFD, licence 80098330: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Licence holder
Arthur Andrew Medical Inc.
NPN or DIN-HM
80098330
Status
Active licence
Licence date
7 April 2020
Revision date
27 May 2021
Form
Capsule
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Serratiopeptidase

Source : Serratia marcescens E-15 - Cellule Entiière

45000.0 SUNot calculated
Serratiopeptidase

Source : Serratia marcescens E-15 - Cellule Entiière

20.45 mgNot calculated
Bromélaïne de fruit

Source : Ananas comosus var. comosus - fruit

25.0 mgNot calculated
Papaïne

Source : Carica papaya - fruit

29.76 mgNot calculated
Triacylglycérol lipase

Source : Candida rugosa - whole

1250.0 FCC LUNot calculated
Triacylglycérol lipase

Source : Candida rugosa - whole

2.0 mgNot calculated
2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl

Source : Coenzyme Q10

5.0 mgNot calculated
Protéase fongique

Source : Aspergillus flavus var. oryzae - En entier

10000.0 FCC HUTNot calculated
Protéase bactérien

Source : Bacillus subtilis - cellule entière

33000.0 Unités de protéase bactérienne du FCCNot calculated

Non-medicinal ingredients

Eau, NA, Hypromellose

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19.0 Année(s)1.0 Capsule1.0 Tous les jours

Uses authorised in Canada

Source of/Provides antioxidants. Digestive enzyme. Used in herbal medicine to help relieve minor pain, swelling and inflammation. Digestive enzyme that helps digest proteins. Helps reduce and/or relieve postoperative cheek swelling and/or pain after dental surgery. Mucolytic enzyme that helps break down mucous. Proteolytic enzyme. Proteolytic enzyme that helps reduce and/or relieve postoperative cheek swelling and/or pain after dental surgery.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80098330

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2021. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

List recorded in 2021. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line